Sun Pharmaceutical Industries Limited
SUNPHARMA
Xếp hạng trong cổ phiếu
#527
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Giá cổ phiếu
$19.24
Vốn hóa thị trường
$46.15B
Thay đổi (1 ngày)
-0.97%
Thay đổi (1 năm)
0.84%
Quốc gia
IN
Giao dịch Sun Pharmaceutical Industries Limited (SUNPHARMA)
Danh mục
Healthcare
EPS của Sun Pharmaceutical Industries Limited (SUNPHARMA)
EPS tính đến June 2026 TTM: $0.56
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của Sun Pharmaceutical Industries Limited, EPS hiện tại của công ty (TTM) là $0.56. Vào cuối năm 2024, công ty có EPS là $0.48, tăng so với EPS năm 2023 là $0.43.
Lịch sử EPS của Sun Pharmaceutical Industries Limited từ 2004 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $0.56 | 4.96% |
| 2025 | $0.53 | 11.41% |
| 2024 | $0.48 | 11.35% |
| 2023 | $0.43 | 139.18% |
| 2022 | $0.18 | 8.71% |
| 2021 | $0.17 | -20.64% |
| 2020 | $0.21 | 30.19% |
| 2019 | $0.16 | 15.61% |
| 2018 | $0.14 | -69.05% |
| 2017 | $0.45 | 56.75% |
| 2016 | $0.29 | -5.81% |
| 2015 | $0.30 | 19.44% |
| 2014 | $0.25 | -4.30% |
| 2013 | $0.27 | 4.58% |
| 2012 | $0.25 | 29.09% |
| 2011 | $0.20 | 35.66% |
| 2010 | $0.14 | -16.31% |
| 2009 | $0.17 | -7.39% |
| 2008 | $0.19 | 94.07% |
| 2007 | $0.10 | 38.62% |
| 2006 | $0.07 | 41.63% |
| 2005 | $0.05 | 19.51% |
| 2004 | $0.04 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CH
|
